- AU$13.54m
- AU$10.20m
- AU$5.33m
Australia Stock Exchange release from ATOMO DIAGNOSTIC : Pause in Trading
Australia Stock Exchange release from ATOMO DIAGNOSTIC : Atomo 2021 Annual General Meeting
Australia Stock Exchange release from ATOMO DIAG : Initial Director's Interest Notice
Australia Stock Exchange release from ATOMO DIAG : Change in substantial holding
Australia Stock Exchange release from ATOMO DIAG : Appointment of Independent Non-Executive Director
Australia Stock Exchange release from ATOMO DIAG : Becoming a substantial holder
Australia Stock Exchange release from ATOMO DIAG : Investor Webinar
Australia Stock Exchange release from ATOMO DIAG : Notification of date of 2021 AGM
Australia Stock Exchange release from ATOMO DIAG : Notification of cessation of securities - AT1
Australia Stock Exchange release from ATOMO DIAG : Appendix 4E & Annual Financial Report
Australia Stock Exchange release from ATOMO DIAG : PRE_NR Ends: 10:43:59
Australia Stock Exchange release from ATOMO DIAG : FY21 Results Presentation
Australia Stock Exchange release from ATOMO DIAG : PRE_NR Ends: 10:59:19
Australia Stock Exchange release from ATOMO DIAG : FY21 Results Investor Briefing
Australia Stock Exchange release from ATOMO DIAG : Ceasing to be a substantial holder
Australia Stock Exchange release from ATOMO DIAG : Change in substantial holding
Australia's Atomo Diagnostics jumps 60% on FDA nod for COVID-19 test kit
Brief: Atomo Diagnostics Says Access Bio Receives FDA Clearance For Covid-19 Antibody Test
Australia Stock Exchange release from ATOMO DIAG : Access Bio receives FDA clearance for COVID-19 antibody test